Kathleen E Sullivan Selected Research

Palmoplantar Keratoderma with Deafness

1/2021

Palmoplantar keratoderma with deafness phenotypic variability in a patient with an inherited GJB2 frameshift variant and novel missense variant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathleen E Sullivan Research Topics

Disease

18	Infections 01/2022 - 05/2003
14	Primary Immunodeficiency Diseases 10/2022 - 01/2002
11	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2002
10	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2020 - 04/2007
9	Inflammation (Inflammations) 01/2022 - 10/2005
8	Granuloma 03/2022 - 11/2017
8	Common Variable Immunodeficiency 01/2019 - 08/2010
7	Rubella (German Measles) 03/2022 - 11/2017
7	DiGeorge Syndrome (Syndrome, DiGeorge) 01/2022 - 10/2003
7	Agammaglobulinemia (Hypogammaglobulinemia) 01/2021 - 10/2007
6	Neoplasms (Cancer) 11/2020 - 07/2006
6	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2020 - 12/2008
6	Human Influenza (Influenza) 11/2013 - 06/2009
4	Virus Diseases (Viral Diseases) 01/2022 - 11/2010
3	Pneumonia (Pneumonitis) 10/2022 - 11/2013
3	Ataxia Telangiectasia (Louis Bar Syndrome) 03/2022 - 07/2006
3	Neutropenia 01/2022 - 01/2018
3	Cytopenia 01/2022 - 01/2018
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 12/2020
3	COVID-19 01/2022 - 11/2020
3	Bruton type agammaglobulinemia 01/2022 - 11/2016
3	Chronic Granulomatous Disease 01/2022 - 12/2002
3	Thrombotic Microangiopathies 12/2021 - 12/2020
3	Hypersensitivity (Allergy) 11/2020 - 09/2015
3	Lymphopenia (Lymphocytopenia) 01/2014 - 07/2006
2	Eosinophilia 01/2022 - 05/2018
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2020
2	Vascular System Injuries 12/2021 - 04/2021
2	Macrophage Activation Syndrome 12/2021 - 04/2021
2	Sensorineural Hearing Loss 11/2021 - 01/2021
2	Sepsis (Septicemia) 05/2021 - 07/2002
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 05/2021 - 01/2017
2	Reinfection 01/2021 - 01/2018
2	Asthma (Bronchial Asthma) 01/2021 - 11/2020
2	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2021 - 05/2012
2	Deafness (Deaf Mutism) 01/2021 - 11/2007
2	Lymphoma (Lymphomas) 11/2020 - 04/2015
2	Leukemia 11/2020 - 11/2016
2	Persistent Infection 01/2020 - 01/2019
2	Hereditary Complement Deficiency Diseases 01/2020 - 12/2017
2	Lymphadenopathy 01/2019 - 09/2006
2	Sarcoma (Soft Tissue Sarcoma) 06/2015 - 08/2014
2	Tetanus 01/2014 - 06/2005
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2013 - 07/2010
2	Splenomegaly 08/2010 - 09/2006
2	Crohn Disease (Crohn's Disease) 08/2009 - 12/2002
2	Autoimmune Lymphoproliferative Syndrome 04/2009 - 09/2006
2	Cutaneous Lupus Erythematosus 12/2002 - 09/2002
2	Dermatomyositis (Dermatopolymyositis) 12/2002 - 09/2002
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2022
1	Leukopenia 01/2022

Drug/Important Bio-Agent (IBA)

12	VaccinesIBA 03/2022 - 10/2003
11	Proteins (Proteins, Gene)FDA Link 12/2021 - 12/2002
10	Immunoglobulins (Immunoglobulin)IBA 10/2022 - 02/2012
9	Immunoglobulin G (IgG)IBA 01/2022 - 10/2007
7	AntibodiesIBA 01/2019 - 06/2005
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2007 - 07/2002
6	CytokinesIBA 11/2020 - 07/2002
4	RNA (Ribonucleic Acid)IBA 03/2022 - 07/2015
4	nitazoxanide (NTZ)FDA Link 03/2022 - 11/2017
4	ChromatinIBA 01/2022 - 03/2015
4	InterferonsIBA 01/2022 - 09/2015
4	Sirolimus (Rapamycin)FDA Link 01/2022 - 09/2006
4	Immunoglobulin E (IgE)IBA 01/2022 - 03/2013
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2013
4	AntigensIBA 01/2021 - 12/2002
4	Histones (Histone)IBA 05/2020 - 01/2015
4	AutoantibodiesIBA 12/2019 - 09/2006
3	Immunoglobulin A (IgA)IBA 10/2022 - 05/2009
3	Pharmaceutical PreparationsIBA 03/2022 - 11/2017
3	CD40 Ligand (CD40L)IBA 01/2022 - 01/2019
3	MicroRNAs (MicroRNA)IBA 05/2021 - 09/2015
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018 - 01/2002
3	histone H3 trimethyl Lys4IBA 01/2018 - 01/2015
3	Antiviral Agents (Antivirals)IBA 11/2017 - 11/2010
2	Rituximab (Mabthera)FDA Link 01/2022 - 02/2013
2	Immunomodulating AgentsIBA 01/2022 - 04/2015
2	ruxolitinibIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2019
2	EnzymesIBA 01/2022 - 01/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 09/2008
2	ProteomeIBA 12/2021 - 04/2021
2	Conditioned Culture MediaIBA 05/2021 - 11/2020
2	Complement System Proteins (Complement)IBA 12/2020 - 01/2020
2	LigandsIBA 12/2019 - 06/2009
2	Antigen Receptors (Antigen Receptor)IBA 01/2019 - 07/2006
2	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 03/2015 - 01/2015
2	Interferon Type IIBA 01/2014 - 11/2010
2	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2013 - 01/2011
2	Interleukin-12 (IL 12)IBA 06/2009 - 08/2008
2	Viral VaccinesIBA 10/2004 - 10/2003
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	baricitinibIBA 01/2022

Therapy/Procedure

21	Therapeutics 10/2022 - 01/2002
10	Cell Transplantation 01/2021 - 12/2008
8	Drug Therapy (Chemotherapy) 12/2017 - 12/2006
6	Hematopoietic Stem Cell Transplantation 01/2022 - 02/2012
4	Transplantation 01/2022 - 05/2005
2	Salvage Therapy 03/2022 - 01/2019
2	Aftercare (After-Treatment) 01/2020 - 09/2008